It’s just one of the far-reaching, trickle-down effects of President Donald Trump’s sweeping executive actions that threaten to slow or halt health and science research in the United States ...
The survey, conducted from December 1-7, 2024, showed that incumbent 2nd District Representative and gubernatorial candidate L-ray Villafuerte trailed in the polls among CSPC students’ governor ...
Significant growth trajectory of the Breast Cancer Application segment, which is expected to reach US$374.1 Million by 2030 ...
Two decades after “The Republican War on Science” was published ... NBC News reported: The National Institutes of Health announced Friday that the agency is making cuts to grants that support ...
The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment ...
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically modified to carry a human gene—for studying hepatitis B virus.
The team of nine global healthcare analysts, some of whom carry advanced degrees in medical or health science, averages over 10 years of industry experience. However, some are more recent hires ...
BlackRock Health Sciences Opps Inv A’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze. Our research ...
June 12, 2023 — Women who used combined contraceptive pills were at greater risk of developing depression than women who did not, according to a new study. Contraceptive pills increased women's ...
Jan. 15, 2025 — Research has established a clear link between racial and ethnic disparities in maternal heart health and higher risks of preterm birth, preeclampsia and cardiovascular issues for ...
AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.
A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The plaintiffs (shareholders) alleged that they bought SAVA stock at artificially ...